Girard Partners Ltd. Sanofi Transaction History

Girard Partners Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$41.48 - $45.59 $143,686 - $157,923	-3,464 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$40.0 - $44.84 $138,560 - $155,325	3,464 New	3,464 $154,000
Q1 2018 Apr 18, 2018	SELL	$38.98 - $45.76 $262,101 - $307,690	-6,724 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$42.86 - $50.61 $6,171 - $7,287	-144 Reduced 2.1%	6,724 $289,000
Q3 2017 Nov 08, 2017	BUY	$47.04 - $50.34 $323,070 - $345,735	6,868	6,868 $342,000

795

252M

2.6M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $145B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Girard Partners Ltd. with notifications on news.